• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CREB1和HINFP作为阿尔茨海默病和帕金森病潜在的共同治疗靶点。

CREB1 and HINFP as Putative Common Therapeutic Targets in Alzheimer's and Parkinson's Disease.

作者信息

Gupta Rohan, Kumar Pravir

机构信息

Molecular Neuroscience and Functional Genomics Laboratory, Department of Biotechnology, Delhi Technological University (Formerly DCE), Delhi 110042, India.

出版信息

ACS Omega. 2021 Dec 16;6(51):35780-35798. doi: 10.1021/acsomega.1c05827. eCollection 2021 Dec 28.

DOI:10.1021/acsomega.1c05827
PMID:34984308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8717564/
Abstract

Integration of omics data and deciphering the mechanism of a biological regulatory network could be a promising approach to reveal the molecular mechanism involved in the progression of complex diseases, including Alzheimer's and Parkinson's. Despite having an overlapping mechanism in the etiology of Alzheimer's disease (AD) and Parkinson's disease (PD), the exact mechanism and signaling molecules behind them are still unknown. Further, the acetylation mechanism and histone deacetylase (HDAC) enzymes provide a positive direction toward studying the shared phenomenon between AD and PD pathogenesis. For instance, increased expression of HDACs causes a decrease in protein acetylation status, resulting in decreased cognitive and memory function. Herein, we employed an integrative approach to analyze the transcriptomics data that established a potential relationship between AD and PD. Data preprocessing and analysis of four publicly available microarray datasets revealed 10 HUB proteins, namely, CDC42, CD44, FGFR1, MYO5A, NUMA1, TUBB4B, ARHGEF9, USP5, INPP5D, and NUP93, that may be involved in the shared mechanism of AD and PD pathogenesis. Further, we identified the relationship between the HUB proteins and transcription factors that could be involved in the overlapping mechanism of AD and PD. CREB1 and HINFP were the crucial regulatory transcription factors that were involved in the AD and PD crosstalk. Further, lysine acetylation sites and HDAC enzyme prediction revealed the involvement of 15 and 27 potential lysine residues of CREB1 and HINFP, respectively. Our results highlighted the importance of HDAC1(K292) and HDAC6(K330) association with CREB1 and HINFP, respectively, in the AD and PD crosstalk. However, different datasets with a large number of samples and wet lab experimentation are required to validate and pinpoint the exact role of CREB1 and HINFP in the AD and PD crosstalk. It is also possible that the different datasets may or may not affect the results due to analysis parameters. In conclusion, our study potentially highlighted the crucial proteins, transcription factors, biological pathways, lysine residues, and HDAC enzymes shared between AD and PD at the molecular level. The findings can be used to study molecular studies to identify the possible relationship in the AD-PD crosstalk.

摘要

整合组学数据并解读生物调控网络的机制,可能是揭示包括阿尔茨海默病和帕金森病在内的复杂疾病进展所涉及分子机制的一种有前景的方法。尽管阿尔茨海默病(AD)和帕金森病(PD)在病因学上有重叠机制,但其背后的确切机制和信号分子仍不清楚。此外,乙酰化机制和组蛋白去乙酰化酶(HDAC)为研究AD和PD发病机制之间的共同现象提供了一个积极的方向。例如,HDACs表达增加会导致蛋白质乙酰化状态降低,从而导致认知和记忆功能下降。在此,我们采用综合方法分析转录组学数据,以建立AD和PD之间的潜在关系。对四个公开可用的微阵列数据集进行数据预处理和分析,发现了10个枢纽蛋白,即CDC42、CD44、FGFR1、MYO5A、NUMA1、TUBB4B、ARHGEF9、USP5、INPP5D和NUP93,它们可能参与AD和PD发病机制的共同机制。此外,我们确定了枢纽蛋白与可能参与AD和PD重叠机制的转录因子之间的关系。CREB1和HINFP是参与AD和PD相互作用的关键调控转录因子。此外,赖氨酸乙酰化位点和HDAC酶预测分别揭示了CREB1和HINFP的15个和27个潜在赖氨酸残基的参与情况。我们的结果突出了HDAC1(K292)和HDAC6(K330)分别与CREB1和HINFP在AD和PD相互作用中的关联的重要性。然而,需要不同的具有大量样本的数据集和湿实验室实验来验证并精确确定CREB1和HINFP在AD和PD相互作用中的确切作用。由于分析参数的原因,不同的数据集也可能会或不会影响结果。总之,我们的研究潜在地突出了AD和PD在分子水平上共享的关键蛋白质、转录因子、生物途径、赖氨酸残基和HDAC酶。这些发现可用于分子研究,以确定AD - PD相互作用中的可能关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ee/8717564/52a3c5b65a44/ao1c05827_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ee/8717564/724aab1cf3f3/ao1c05827_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ee/8717564/9f81aee9771d/ao1c05827_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ee/8717564/442ccfe8b04f/ao1c05827_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ee/8717564/f3264f22f58a/ao1c05827_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ee/8717564/ec0fb51df900/ao1c05827_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ee/8717564/52a3c5b65a44/ao1c05827_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ee/8717564/724aab1cf3f3/ao1c05827_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ee/8717564/9f81aee9771d/ao1c05827_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ee/8717564/442ccfe8b04f/ao1c05827_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ee/8717564/f3264f22f58a/ao1c05827_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ee/8717564/ec0fb51df900/ao1c05827_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ee/8717564/52a3c5b65a44/ao1c05827_0007.jpg

相似文献

1
CREB1 and HINFP as Putative Common Therapeutic Targets in Alzheimer's and Parkinson's Disease.CREB1和HINFP作为阿尔茨海默病和帕金森病潜在的共同治疗靶点。
ACS Omega. 2021 Dec 16;6(51):35780-35798. doi: 10.1021/acsomega.1c05827. eCollection 2021 Dec 28.
2
An integrated approach to unravel a putative crosstalk network in Alzheimer's disease and Parkinson's disease.一种综合方法来揭示阿尔茨海默病和帕金森病中假定的串扰网络。
Neuropeptides. 2020 Oct;83:102078. doi: 10.1016/j.npep.2020.102078. Epub 2020 Aug 12.
3
Computational Analysis Indicates That PARP1 Acts as a Histone Deacetylases Interactor Sharing Common Lysine Residues for Acetylation, Ubiquitination, and SUMOylation in Alzheimer's and Parkinson's Disease.计算分析表明,PARP1作为一种组蛋白去乙酰化酶相互作用蛋白,在阿尔茨海默病和帕金森病中共享用于乙酰化、泛素化和SUMO化的常见赖氨酸残基。
ACS Omega. 2021 Feb 19;6(8):5739-5753. doi: 10.1021/acsomega.0c06168. eCollection 2021 Mar 2.
4
Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer's disease, Parkinson's disease, and multiple sclerosis.整合单细胞序列分析揭示阿尔茨海默病、帕金森病和多发性硬化症的转录动态。
J Transl Med. 2023 Sep 21;21(1):649. doi: 10.1186/s12967-023-04516-6.
5
Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.在斑马鱼模型中对HDAC1和HDAC6进行体内药理学调节:对帕金森病的治疗意义。
Pharmacol Res. 2016 Jan;103:328-39. doi: 10.1016/j.phrs.2015.11.024. Epub 2015 Dec 3.
6
Preliminary study to identify CXCR4 inhibitors as potential therapeutic agents for Alzheimer's and Parkinson's diseases.作为潜在的治疗阿尔茨海默病和帕金森病的药物,对 CXCR4 抑制剂进行初步研究。
Integr Biol (Camb). 2023 Apr 11;15. doi: 10.1093/intbio/zyad012.
7
Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?组蛋白去乙酰化酶的表观遗传学靶向:帕金森病的治疗潜力?
Pharmacol Ther. 2013 Oct;140(1):34-52. doi: 10.1016/j.pharmthera.2013.05.010. Epub 2013 May 24.
8
Molecular crosstalk between COVID-19 and Alzheimer's disease using microarray and RNA-seq datasets: A system biology approach.利用微阵列和RNA测序数据集研究COVID-19与阿尔茨海默病之间的分子相互作用:一种系统生物学方法。
Front Med (Lausanne). 2023 Jun 7;10:1151046. doi: 10.3389/fmed.2023.1151046. eCollection 2023.
9
Histone Acetylation Modifiers in the Pathogenesis of Alzheimer's Disease.组蛋白乙酰化修饰因子在阿尔茨海默病发病机制中的作用
Front Cell Neurosci. 2015 Jun 16;9:226. doi: 10.3389/fncel.2015.00226. eCollection 2015.
10
Genetic networks in Parkinson's and Alzheimer's disease.帕金森病和阿尔茨海默病中的遗传网络。
Aging (Albany NY). 2020 Mar 23;12(6):5221-5243. doi: 10.18632/aging.102943.

引用本文的文献

1
Tit wit: environmental and genetic drivers of cognitive variation along an urbanization gradient.标题:城市化梯度上认知差异的环境与遗传驱动因素
Anim Cogn. 2025 Jul 3;28(1):56. doi: 10.1007/s10071-025-01962-1.
2
A review and analysis of key biomarkers in Alzheimer's disease.阿尔茨海默病关键生物标志物的综述与分析
Front Neurosci. 2024 Feb 20;18:1358998. doi: 10.3389/fnins.2024.1358998. eCollection 2024.
3
Identification of key lipid metabolism-related genes in Alzheimer's disease.阿尔茨海默病中关键脂质代谢相关基因的鉴定。

本文引用的文献

1
Investigating Crosstalk Among PTMs Provides Novel Insight Into the Structural Basis Underlying the Differential Effects of Nt17 PTMs on Mutant Httex1 Aggregation.研究翻译后修饰之间的相互作用为Nt17翻译后修饰对突变型Httex1聚集产生不同影响的结构基础提供了新见解。
Front Mol Biosci. 2021 Jul 26;8:686086. doi: 10.3389/fmolb.2021.686086. eCollection 2021.
2
LMK235, a small molecule inhibitor of HDAC4/5, protects dopaminergic neurons against neurotoxin- and α-synuclein-induced degeneration in cellular models of Parkinson's disease.LMK235,一种HDAC4/5小分子抑制剂,在帕金森病细胞模型中可保护多巴胺能神经元免受神经毒素和α-突触核蛋白诱导的变性。
Mol Cell Neurosci. 2021 Sep;115:103642. doi: 10.1016/j.mcn.2021.103642. Epub 2021 Jun 10.
3
Lipids Health Dis. 2023 Sep 22;22(1):155. doi: 10.1186/s12944-023-01918-9.
4
Neobaicalein prevents isoflurane anesthesia-induced cognitive impairment in neonatal mice via regulating CREB1.新白杨素通过调节 CREB1 预防异氟醚麻醉诱导的新生小鼠认知功能障碍。
Clinics (Sao Paulo). 2023 Apr 28;78:100201. doi: 10.1016/j.clinsp.2023.100201. eCollection 2023.
5
Proteomic Analysis of Protective Effects of Dl-3-n-Butylphthalide against mpp + -Induced Toxicity via downregulating P53 pathway in N2A Cells.通过下调N2A细胞中P53通路研究丁苯酞对1-甲基-4-苯基吡啶离子诱导毒性的保护作用的蛋白质组学分析
Proteome Sci. 2023 Jan 3;21(1):1. doi: 10.1186/s12953-022-00199-x.
Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease.
活化的小胶质细胞促进帕金森病中α-突触核蛋白的传递。
Neurochem Int. 2021 Sep;148:105094. doi: 10.1016/j.neuint.2021.105094. Epub 2021 Jun 8.
4
Nicotine suppresses Parkinson's disease like phenotypes induced by Synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels.尼古丁通过增加酪氨酸羟化酶和多巴胺水平抑制 Synphilin-1 过表达诱导的果蝇帕金森病样表型。
Sci Rep. 2021 May 5;11(1):9579. doi: 10.1038/s41598-021-88910-4.
5
A novel SIRT6 activator ameliorates neuroinflammation and ischemic brain injury EZH2/FOXC1 axis.一种新型SIRT6激活剂通过EZH2/FOXC1轴改善神经炎症和缺血性脑损伤。
Acta Pharm Sin B. 2021 Mar;11(3):708-726. doi: 10.1016/j.apsb.2020.11.002. Epub 2020 Nov 7.
6
Role of connexins in neurodegenerative diseases (Review).连接蛋白在神经退行性疾病中的作用(综述)
Mol Med Rep. 2021 May;23(5). doi: 10.3892/mmr.2021.12034. Epub 2021 Mar 24.
7
Computational Analysis Indicates That PARP1 Acts as a Histone Deacetylases Interactor Sharing Common Lysine Residues for Acetylation, Ubiquitination, and SUMOylation in Alzheimer's and Parkinson's Disease.计算分析表明,PARP1作为一种组蛋白去乙酰化酶相互作用蛋白,在阿尔茨海默病和帕金森病中共享用于乙酰化、泛素化和SUMO化的常见赖氨酸残基。
ACS Omega. 2021 Feb 19;6(8):5739-5753. doi: 10.1021/acsomega.0c06168. eCollection 2021 Mar 2.
8
INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia.INPP5D 表达与阿尔茨海默病的风险相关,并受斑块相关小胶质细胞诱导。
Neurobiol Dis. 2021 Jun;153:105303. doi: 10.1016/j.nbd.2021.105303. Epub 2021 Feb 22.
9
Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment.综合网络分析揭示新基因提示 COVID-19 慢性影响和治疗。
Brief Bioinform. 2021 Mar 22;22(2):1430-1441. doi: 10.1093/bib/bbaa417.
10
Altered Expression of Glial Gap Junction Proteins Cx43, Cx30, and Cx47 in the 5XFAD Model of Alzheimer's Disease.阿尔茨海默病5XFAD模型中胶质细胞间隙连接蛋白Cx43、Cx30和Cx47的表达改变
Front Neurosci. 2020 Oct 7;14:582934. doi: 10.3389/fnins.2020.582934. eCollection 2020.